title: Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation.
authors.affiliation: Medical Clinic I, University Hospital Carl Gustav Carus, Dresden, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Schönefeldt
authors.forename: K
authors.initials: K
authors.lastname: Sockel
authors.forename: R
authors.initials: R
authors.lastname: Wehner
authors.forename: S
authors.initials: S
authors.lastname: Sopper
authors.forename: D
authors.initials: D
authors.lastname: Wolf
authors.forename: M
authors.initials: M
authors.lastname: Wermke
authors.forename: C
authors.initials: C
authors.lastname: Thiede
authors.forename: U
authors.initials: U
authors.lastname: Oelschlägel
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: M
authors.initials: M
authors.lastname: Bornhäuser
authors.forename: U
authors.initials: U
authors.lastname: Platzbecker
authors.forename: M
authors.initials: M
authors.lastname: Schmitz